Conditions: TNF-receptor Associated Periodic Syndromes (TRAPS)
Keywords: TNF-receptor associated periodic syndrome fevers rashes musculoskeletal and abdominal pain periorbital edema TNFR1
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 20
Healthy volunteers: no

Brief summary:
This trial will assess the safety and efficacy of ACZ885 in patients with active recurrent or chronic TNF-receptor associated periodic syndrome (TRAPS).

Detailed description:

Arms:
arm 1: This was an open-label, single treatment arm, multicenter study of monthly canakinumab 150 mg (2 mg/kg for patient ≤ 40 kg) subcutaneous injections in patients with active recurrent or chronic TRAPS.

Interventions: intervention 1: ACZ885
Intervention descriptions: intervention 1: None

Protocol document: